Tag: Phase 2 clinical study

October 8, 2019

Novan’s Phase 2 SB206 Study Published in Journal of American Academy of Dermatology

The company's results from its Phase 2 SB206 trial were published in the Journal of the American Academy of Dermatology.
September 18, 2019

vTv Therapeutics Presents Additional Positive Data from the Phase 2 Simplici-T1 Study

The study evaluated patients with type 1 diabetes and was presented at the Meeting of the European Association for the...
June 13, 2019

Progenics Pharmaceuticals Doses First Patient in Phase 2 Clinical Study of 1095 Radiotherapy

Progenics Pharmaceuticals (NASDAQ:PGNX) has announced the first patient in its Phase 2 clinical trial studying I-131 1095 radiotherapy has been...
January 16, 2019

Aptinyx Reports Top-line Results from Phase 2 Clinical Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy

Aptinyx (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced...
May 10, 2018

Aptevo Therapeutics Reports First Quarter 2018 Financial Results

Aptevo Therapeutics (Nasdaq:APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, today provided a business review and...
April 27, 2018

Cytokinetics Reports First Quarter 2018 Financial Results

Cytokinetics (Nasdaq:CYTK) reported financial results for the first quarter of 2018. Net loss for the first quarter was $30.3 million,...
April 19, 2018

Kalytera Announces Issuance of Patent Covering the Use of CBD for the Treatment of Severe and Refractory Graft Versus Host Disease

Kalytera Therapeutics, Inc. (TSXV:KALY. OTCQB:KALTF) announced that the U.S. Patent and Trademark Office ("USPTO") issued U.S. Patent No. 9,889,100 B2...